During the past decade, Nemocnice Jindrichuv Hradec, a.s. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nemocnice Jindrichuv Hradec, a.s." are "Prostate Cancer" (3 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Nemocnice Jindrichuv Hradec, a.s." in a lesser frequency.

Most popular intervention types in "Nemocnice Jindrichuv Hradec, a.s." are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (2 trials), "Goserelin acetate" (2 trials), "Degarelix 160 mg / Degarelix 160 mg" (1 trials), "Degarelix 80 mg / Degarelix 80 mg" (1 trials) and "Leuprolide 7.5 mg / Degarelix 160 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Jindrichuv Hradec, a.s." are 3 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnice Jindrichuv Hradec, a.s.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nemocnice Jindrichuv Hradec, a.s., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Jindrichuv Hradec, a.s., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".